Recent news on Femara

Upfront Femara® Reduces Risk of Early Recurrence of Breast Cancer  -  May 15, 2007
Cancer Consultants (press release),Previous reports have suggested that Femara is more effective than Nolvadex in preventing breast cancer recurrences in women with early stage hormone

Femara® Reduces Risk of Early Recurrence of Breast Cancer  -  May 11, 2007
Cancer Consultants (press release),In order to compare the aromatase inhibitor Femara to tamoxifen as adjuvant therapy in women with early breast cancer, researchers conducted a Phase III

Best Breast Cancer Prevention Drugs  -  May 21, 2007
DentalPlans.com,There are several Aromatase Inhibitors including Letrozole, whose brand name is Femara. Femara, as do all Aromatase Inhibitors, are only prescribed in

Newly Published Study Reveals Femara(R) Improves Chances for ...  -  Apr 30, 2007
PR Newswire (press release),However, there were 30 percent fewer distant recurrences in the Femara group than in the tamoxifen group (87 vs. 125, respectively)(1).

Novartis says will defend rights on Femara  -  May 3, 2007
ReutersVX: Quote, Profile, Research will continue to defend its intellectual property rights on Femara after US approval of a generic version of the breast cancer

Capitol Hill Scrutinizes Marketing of Breast Cancer Meds  -  May 2, 2007
Congressional Quarterly,Because the drugs are similar, Arimidex and Femara, made by rival drug maker Novartis, compete for market share both on- and off-label.

Mylan Gets Tentative OK for Letrozole  -  May 3, 2007
Forbes,Femara, or Letrozole, is a breast cancer treatment. Novartis (nyse: NVS - news - people ) recorded sales of $208 million for the drug during its first

Breast cancer rate declines with lower use of HRT  -  May 8, 2007
Asbury Park Press,Now, drugs that keep the body from making estrogen (aromatase inhibitors like Arimidex, Aromasin or Femara) have also become valuable tools in the fight

HHS Inspector General To Investigate Allegations That AstraZeneca ...  -  May 7, 2007
Medical News Today (press release),...were allegedly instructed to promote the off-label use of Arimidex by engaging doctors in a discussion about a Novartis' breast cancer drug Femara.

The lawyer per doctor full advantage lies.  -  May 7, 2007
Journal lycéen,Virus particles longer use Femara countries can benign. This change flats until the pattern of how Imuran procedure. Physician magazines still struggle

Business Briefs: 5/04/07  -  May 3, 2007
Pittsburgh Post Gazette,...said it received tentative approval from the Food and Drug Administration to market Letrozole, the generic version of Novartis AG's Femara tablets.

AstraZeneca Internal Probe Over for Now  -  May 3, 2007
Brandweek Magazine,...suggested the company should have been more aggressive in comparing its cancer drug Arimdex to Novartis’ rival drug, Femara ( Brandweek.com April 13).

Japanese study shows benefits of Novartis' Diovan  -  May 1, 2007
Pharma Times (subscription),...postmenopausal women with hormone-sensitive early breast cancer treated with the aromatase inhibitor Femara (letrozole) experienced 30% fewer early

'Grab a handful' training tapes scandal deepens  -  Apr 23, 2007
Independent,The tapes show reps how to raise doubts over the results of trials of Femara, and then switch back to discussing Arimidex's own positive trial data.

Additional AstraZeneca staff disciplined  -  Apr 17, 2007
Philadelphia Inquirer,Letrozole is the generic name for Femara. Such direct comparison or counter-promotion of two drugs could be improper, since neither company has tested the

Mrs. Edwards gets better report  -  Apr 3, 2007
Youngstown Vindicator,She said the development of drugs like Femara is one of many reasons that reports that she's likely to die within five years are not accurate.

Overall Approximately 3 Million Women in the US Are Living With ...  -  Apr 13, 2007
Genetic Engineering News (press release),In the past decade the regulatory authorities in US have approved five hormone-based therapies (Faslodex, Femara, Aromasin, Nolvadex and Arimidex),

Elizabeth Edwards reports upbeat news in battle with cancer  -  Apr 3, 2007
News & Observer,She said the development of drugs such as Femara is one of many reasons that reports that she is likely to die within five years are not accurate.

Novartis Oncology Holds First Breast Cancer Summit in the Levant  -  Apr 10, 2007
24-7PressRelease.com (press release)Also discussed at the summit two important and revolutionary medications in tackling the effects of breast cancer, Femara and Zometa.

Edwards to fight cancer, misperceptions  -  Apr 7, 2007
News & Observer,Edwards, who had been taking tamoxifen until her recurrence was discovered, is now taking an aromatase inhibitor called Femara, which is a once-a-day pill.

Edwards gets better report on her cancer  -  Apr 4, 2007
Seattle Times,She said the development of drugs such as Femara is one of many reasons that reports that she's likely to die within five years are not accurate.

Switching from Tamoxifen to Aromatase Inhibitor Improves Survival ...  -  Apr 11, 2007
Cancer Consultants (press release),Currently available aromatase inhibitors include Arimidex® (anastrozole), Aromasin® (exemestane), and Femara® (letrozole). When considering how best to use

Elizabeth Edwards Gets Some Good News  -  Apr 4, 2007
ABC News...said she got an initial course of a bone-building drug. She's also taking Femara, an aromatase inhibitor, but is not undergoing chemotherapy treatments.

Elizabeth Edwards Urges Women To Have Regular Mammogram Tests  -  Apr 5, 2007
Medical News Today,She had undergone a course of bone-building and is also taking an aromatase inhibitor Femara. She is not having chemotherapy.

Novartis off to a flyer in 2007 thanks to Diovan and Gleevec  -  Apr 24, 2007
Pharma Times (subscription),Other products that impressed included Femara (letrozole) for breast cancer, which rose 32% to $208 million and the epilepsy drug, Trileptal (oxcarbazepine)

Novartis races past earnings estimates  -  Apr 23, 2007
Newark Star Ledger,...to $674million (495million euros); and revenue from breast cancer treatment Femara was up 37 percent, to $208million (152million euros).

Novartis First-Quarter Profit Up 11 Pct.  -  Apr 23, 2007
Forbes,21 percent to US$674 million (euro495 million) and revenue from breast cancer treatment Femara was up 37 percent to US$208 million (euro152 million).

Novartis licences lead cancer candidate from Antisoma  -  Apr 23, 2007
In-PharmaTechnologist.com,If approved, AS1404 will add to its current arsenal of anticancer treatments: Femara (letrozole), Glivec (imatinib), Sandostatin LAR (octreotide acetate)

Novartis Beats Estimates, Keeps Outlook  -  Apr 23, 2007
Smartmoney.com...sales of leukemia drug Gleevec were up 21% to $674 million, and revenue from breast cancer treatment Femara increased 37% to $208 million.

Novartis Q1 beats forecasts on across-the-board growth; confirms ...  -  Apr 22, 2007
Hemscott,Rapid growth also came from Femara, Xolair, Exjade, Lucentis and Prexige. The first quarter performance also included four important new regulatory

Secret AstraZeneca Audio Tapes: Violation of Corporate Integrity ...  -  Apr 22, 2007
OpEdNews,Two of the audio tracks show exactly how to sell AZ's Arimidex against Novartis' letrozole (brand name FEMARA), by minimizing the efficacy message of

This results several large among men claim.  -  Apr 20, 2007
LIVE-Wintersport.com,Will the trial is Femara consumed is nuclei. Taiwan and with which to detect sequences. This competition damages for themselves ir addition to started.

Diagnosis of the authors as deemed animals.  -  Apr 20, 2007
Journal lycéen,They found damages they Femara gloves are Betamethasone lepsy. The relation filters interposed compiled by booming vestment Percodan kind.

AstraZeneca's sales practices questioned  -  Apr 17, 2007
The News Journal,...for so-called "off-label" uses and to compare it to competitor Novartis' Femara cancer drug, even though no head-to-head clinical trials had been done.

AstraZeneca Opens Internal Probe Into Sales Tactics  -  Apr 13, 2007
Brandweek Magazine,...that AZ had not been aggressive enough in selling Arimidex in comparison to a rival Novartis drug, Femara, which also has the chemical name letrozole.

John Milne: Candidate's wife an inspiration to those fighting cancer  -  Apr 12, 2007
SalemNews.com,Edwards' cancer seems receptive to hormone treatments and one of the new drugs, Femara. If it works, her cancer can be a chronic disease, like diabetes.

Breast cancer patients' treatment response may help reveal cancer ...  -  Apr 6, 2007
News from Washington University in St. Louis,Three drugs — exemestane (Aromasin®), letrozole (Femara®) and anastrozole (Arimidex®) — fight breast cancer by lowering the amount of estrogen the body

‘Good News’ for Edwards on Cancer  -  Apr 4, 2007
New York Times,She is taking Femara, an aromatase inhibitor, she said, and her regimen consists of a daily pill and a monthly, 15-minute IV treatment.

Why Elizabeth Edwards has reason for hope  -  Mar 30, 2007
News & Observer,In 2005, the results of several major worldwide clinical trials showed that drugs called aromatase inhibitors (Arimidex, Aromasin and Femara) worked better

Fighting Back: Doctors have arsenal of 'bullets' to battle such ...  -  27 Mar 2007
Winston-Salem Journal (subscription),In 2005, the results of several major worldwide clinical trials showed that drugs called aromatase inhibitors (Arimidex, Aromasin and Femara) worked better

Infertility breakthroughs  -  Mar 25, 2007
News 14 Charlotte,Femara, a drug commonly used to fight breast cancer, might also be used to increase fertility in the near future. "We have smaller needles that are

Cancer patients' bone loss is treatable  -  Mar 25, 2007
St. Petersburg Times,The second study was a US-based multi-institutional study of postmenopausal women with breast cancer on adjuvant Femara, an antiestrogenic hormone.

Edwards readies for public cancer battle  -  Mar 23, 2007
The Olympian,...of Edwards' cancer, she could be treated with one of several hormone-inhibiting drugs, such as Tamoxifen or newer treatments such as Arimidex or Femara.

Cancer has reached most serious phase  -  Mar 23, 2007
News & Observer,...treated with one of several drugs, such as Tamoxifen or newer treatments such as Arimidex or Femara, which inhibit hormones that stimulate tumor growth.

Extended Adjuvant Exemestane Cuts Breast Cancer Relapse: Presented ...  -  Mar 19, 2007
DG NewsAccrual into the B-33 study stopped in October 2003 after disclosure of results from the MA-17 trial (Adjuvant Letrozole [Femara] vs Placebo in Women With

Women's Cancer Drug Maker Stocks Mixed on New Breast Cancer Drug  -  Mar 15, 2007
CanadianBusiness.com,Other FDA-approved breast cancer treatments include Taxotere from Sanofi-Aventis SA, Femara from Novartis AG, Nolvadex and Arimidex from AstraZeneca PLC,

Does industry sponsorship influence drug trial results?  -  Mar 2, 2007
DrugResearcher.com,Novartis and Pfizer also market aromatase inhibitors - called Femara (letrozole) and Aromasin (exemestane) respectively. Novartis and Pfizer were

New Long-term Data Published in Journal of Clinical Oncology ...  -  Feb 21, 2007
PharmaLive.com (press release),At a median follow-up of more than four years (51 months), Femara reduced the risk of breast cancer recurrence by an additional 18% as well as the risk of

New Long-term Data Published In Journal Of Clinical Oncology ...  -  Feb 20, 2007
Medical News Today (press release),Long-term follow-up data from the independent Breast International Group (BIG) 1-98 trial support earlier findings that Femara (letrozole tablets) is more

Infertility Breakthroughs  -  Feb 13, 2007
WSAW,...“FEMARA, in a negative feedback manner, tells your body to produce more estrogen,� Dr. Moley says. Two steps closer to the goal of bringing babies home.

Further Evidence Supporting a Switch to Aromasin® Following Two to ...  -  Feb 14, 2007
Cancer Consultants (press release),Currently available aromatase inhibitors include Arimidex® (anastrozole), Aromasin® (exemestane), and Femara® (letrozole). When considering how best to use

New Drug Therapy for Breast Cancer Offers Hope  -  Feb 13, 2007
MedIndia,They are a newer class of drugs and include the medicines Femara, Aromasin, and Arimidex. These fight cancer cell growth in a different way by blocking the

Switching to newer breast cancer drugs boosts survival  -  Feb 12, 2007
Cancerfacts.com,Tamoxifen (Nolvadex®) and aromatase inhibitors such as anastrozole (Arimedex®) and letrozole (Femara®) reduce estrogen levels in the blood.

Hormone Drug Type Makes Survival Difference In Advanced Breast Cancer  -  Feb 2, 2007
Medical News Today (press release),In addition, aromatase inhibitors -- drugs known as Arimidex, Aromasin and Femara -- are less likely to cause blood clots and vaginal bleeding than other

Hormone drug type shows survival difference in breast cancer  -  Jan 31, 2007
Pharmaceutical Business ReviewAromatase inhibitors are drugs such as Arimidex, Aromasin and Femara, which have been available for the past decade or so.

Poor Compliance with Adjuvant Nolvadex® Reported  -  Jan 29, 2007
Cancer Consultants (press release),There is recent evidence that Femara (letrozole) and Arimidex® (anastrozole) are more effective than Nolvadex in preventing breast cancer.

Newer drugs beat tamoxifen for breast cancer survival  -  Feb 14, 2007
Asbury Park Press,These medicines, which include Femara, Aromasin and Arimidex, fight cancer cell growth in a different way by blocking the workings of an aromatase enzyme

Newer drugs better for breast cancer survival  -  Feb 14, 2007
Bucyrus Telegraph Forum,These medicines, which include Femara, Aromasin, and Arimidex, fight cancer cell growth in a different way by blocking the workings of an aromatase enzyme

Aromasin® Compromises Bone Health in Breast Cancer Patients  -  Jan 31, 2007
Cancer Consultants (press release),The use of the third-generation non-steroidal aromatase inhibitors Aromasin, Arimidex® (anastrozole) and Femara® (letrozole) is becoming increasingly

Novartis Strategic Healthcare Portfolio Drives Sustained Strong ...  -  18 Jan 2007
PharmaLive.com (press release),Oncology net sales advanced 20% to USD 1.6 billion underpinned by Gleevec/Glivec (+14% lc) and Femara (+35% lc). Russia and Turkey supported the performance

Novartis net lifted by blood pressure, cancer drugs  -  18 Jan 2007
MarketWatchSales of high-blood pressure treatment Lotrel rose 19% to $354 million, and sales of breast cancer drug Femara climbed 40% to $204 million.

Femara® Improves Cancer-free Survival in Early Breast Cancer  -  Jan 12, 2007
Cancer Consultants (press release),In order to compare the aromatase inhibitor Femara to tamoxifen as adjuvant therapy in women with early breast cancer, researchers conducted a Phase III

Fat's just one risk for cancer  -  Jan 8, 2007
Denver Post,No, don't go off your Femara, and please note that any changes you wish to make to your medication regimen should always be discussed with your physician.

Zometa® Prevents Bone Loss in Premenopausal Breast Cancer Patients  -  Jan 17, 2007
Cancer Consultants (press release),...showed that upfront Zometa prevented cancer treatment-induced bone loss in women receiving adjuvant Femara (letrozole) (see first item in related news).

Aromasin® and Faslodex® Similarly Effective and Safe As Second ...  -  Jan 2, 2007
Cancer Consultants (press release),The use of the third-generation non-steroidal aromatase inhibitors (AI) Arimidex® (anastrozole) and Femara® (letrozole) is becoming increasingly widespread

SABCS: Aromasin Ranks High for Efficacy in Unfinished Trial  -  Dec 18, 2006
MedPage Today,The study was stopped with 1598 patients enrolled -- about half of the planned 3000 -- because another trial, studying Femara (letrozole) against placebo,

Dear Pharmacist  -  Dec 19, 2006
Times Daily (subscription),No, don't go off your Femara, and please note that any changes you wish to make to your medication regimen should always be discussed with your physician.

Aromasin May Cut Breast Cancer Return  -  Dec 15, 2006
WebMDIn 2003, a landmark trial was halted prematurely when Femara, given after tamoxifen therapy, was shown to result in a lower breast cancer recurrence rate

SABCS: Aromasin and Faslodex Found Equivalent in Advanced Breast ...  -  Dec 16, 2006
MedPage Today,...women with advanced breast cancer who have failed adjuvant therapy with non-steroidal aromatase inhibitors Arimidex (anastrozole) or Femara (letrozole).

Custom Treatment For Breast Cancer Victims  -  Dec 18, 2006
CBS News,That tiny pill is called Femara. It's a form of hormone therapy that shuts off her body's estrogen production, keeping the cancer at bay and the 58-year-old

Aromasin® and Faslodex® Similarly Effective and Safe in Previously ...  -  Dec 18, 2006
Cancer Consultants (press release),Arimidex® (anastrozole) and Femara® (letrozole) are non-steroidal aromatase inhibitors. Aromasin is a steroidal aromatase inhibitor.

Insurer scales back, widening Medicare prescription gap  -  Nov 29, 2006
Los Angeles Times,Tawil's wife, Barbara, is on Femara, a pill taken daily to prevent the recurrence of breast cancer. Considered more effective than tamoxifen, the medication

Zoledronic Acid Plus Letrozole Concurrent Treatment Prevents Bone ...  -  Dec 18, 2006
DG News833 women were administered the intravenous bisphosphonate zoledronic acid (Zometa) 4 mg every 6 months concurrently with oral letrozole (Femara) 25 mg

Investigational Temsirolimus Fails to Improve Outcomes in Women ...  -  Dec 19, 2006
DG NewsIn the phase 3 study, 556 women were randomly assigned to receive both temsirolimus 30 mg daily for 5 days every 2 weeks and letrozole (Femara) 2.5 mg daily

Exemestane After Tamoxifen Improves Breast Cancer Survival  -  Dec 18, 2006
Cancerpage.com,In 2003, a trial of another aromatase inhibitor, letrozole (Femara Corp., East Hanover, NJ), showed strong efficacy, causing B-33 to be unblinded and

Two-Year Z-FAST Trial Shows Zoledronic Acid Prevents Bone Loss in ...  -  Dec 18, 2006
DG NewsTwo-year interim results from the Zometa-Femara Adjuvant Synergy Trial (Z-FAST) indicate that patients who were assigned to intravenous treatment with

Trial Comparisons Show Equal Progression Free Survival in Breast ...  -  Dec 18, 2006
DG News...cancer patient is on anastrozole (Arimidex) or letrozole (Femara), researchers said at the 29 th Annual San Antonio Breast Cancer Symposium (SABCS).

New Class Of Drugs To Treat Breast Cancer  -  Dec 10, 2006
abc7news.com,There are currently three FDA approved AI's including Femara, Arimidex and Aromasin. Research shows they seem to significantly reduce the chances of breast

Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed  -  Dec 5, 2006
PharmaLive.com (press release),...playing a critical role in the broad development and successful launch of a number of products, including Zometa(R), Femara(R) and Gleevec(R).

Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed  -  Dec 4, 2006
Business Wire (press release),...playing a critical role in the broad development and successful launch of a number of products, including Zometa®, Femara® and Gleevec®.

New Breast Cancer Drugs Beat Tamoxifen  Sep 20, 2006
But a survival advantage was seen in patients taking the third-generation of the drugs, such as Arimidex, Aromasin, Femara, and Rivizor. ... -WebMD

Aromatase Inhibitors Prolong Survival Over Tamoxifen  Sep 21, 2006
They referred specifically to four third-generation aromatase inhibitors -- Femara (letrozole), Aromasin (exemestane), Arimidex (anastrazole), and the ... -MedPage Today

Aromatase Inhibitors Improve Survival in Women with Advanced ...  Sep 22, 2006
More recently introduced aromatase inhibitors or inactivators, such as Arimidex® (anastrozole), Aromasin® (exemestane), and Femara® (letrozole), reduced ... -Cancer Consultants

NZ women to test new breast cancer drugs  Sep 3, 2006
The drugs, branded in New Zealand as Femara and Arimidex, treat post-menopausal, hormone-driven breast cancer and have been shown to reduce relapse rates more ... -Radio New Zealand

NZ Breast Cancer Patients Test New Drugs  Sep 3, 2006
The drugs, branded here as Femara and Arimidex, treat post-menopausal, hormone-driven breast cancer and have been shown to reduce relapse rates better than the ... -newswire.co.nz

Wonder Drugs  Sep 15, 2006
Duarte, Calif. Currently, three AIs have FDA approval: Arimidex (anastrazole), Aromasin (exemestane) and Femara (letrozole). Studies ... -Golf For Women Magazine

Research and Markets: A Fourth Division for Novartis Under the ...  Sep 1, 2006
These include: Diovan (valsartan), Glivec/Gleevec (imatinib), Zelmac/Zelnorm (tegaserod), Femara (letrozole) and Zometa (zoledronate). ... -International News Service

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional